Item 2.02 Regulation FD Disclosure
On August 1, 2022, Omega Healthcare Investors, Inc. (“Omega”) issued a press
release regarding its financial results for the quarter ended June 30, 2022.
Omega’s press release is attached as Exhibit 99.1 to this Current Report on Form
8-K and incorporated by reference herein.
The information in this Item 2.02 of this Current Report on Form 8-K and the
Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section
18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise
subject to the liabilities of that section, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, regardless of any general incorporation language in such filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit No. Description of Exhibit
99.1 Press release issued by the Company on August 1, 2022.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source Glimpses
postbrexitcompliance.com 